4 High-Yield Healthcare Stocks Retirees Should Buy for December Income

Published November 18, 2026, 10:00am ET · 5 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

An elderly woman sitting in a wheelchair in a white robe, looking to the left
© Neustockimages / iStock via Getty Images

Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income heading into the new year. The quality of that income varies widely, though. These four names pair a 49-year dividend grower, a turnaround insurer and pharmacy chain, a cash-rich drug distributor and a skilled nursing REIT. Each one gets judged on cash coverage before yield. The anchor is Medtronic (NYSE:MDT | MDT Price Prediction), whose latest payout marked its 49th consecutive year of dividend increases[1].

Medtronic: A 49-Year Dividend Grower With Rising Free Cash Flow

Current yield: At a share price of $100 and an annualized forward dividend of $2.88, Medtronic yields about 2.88%.

Dividend safety: The payout equals roughly 48% of the midpoint of fiscal 2027 non-GAAP EPS guidance of $5.94 to $6.00[2]. That leaves a wide buffer. Cash backs it up. Free cash flow in Q1 FY27 reached $1.29B[2], up 120.89% year over year, against $921M in dividends paid, so dividends used about 71% of the quarter’s free cash flow. For full-year FY26, free cash flow came in at $5.426B[1], and the company still bought back $1.035B of shares. The quarterly dividend has moved from $0.50 in 2017 to $0.72 today.

Bull case: Growth is accelerating. Q1 FY27 revenue rose 13.73%[2] to $9.756B, Electrophysiology Therapies grew 29.5% and Cardiac Ablation Solutions jumped 88%. Management raised its FY27 organic growth outlook to 7.25% to 7.75%, and a fresh FDA clearance for its surgical robot broadens the addressable market, according to Barron’s. The stock pairs dividend growth with a moderate valuation, trading at roughly 17 times the guidance midpoint.

Risk: The planned Diabetes separation adds execution risk. Q1 growth also got help from an extra fiscal week worth about $570 million, which will flatter year-over-year comparisons this year.

CVS Health: A Low Payout Ratio and a Turnaround Gaining Speed

Current yield: CVS Health (NYSE:CVS) pays $2.66 per share annually. At $85.32, it yields about 3.12%.

Dividend safety: The dividend uses only about 32% of the raised 2026 adjusted EPS floor of at least $8.20. Year-to-date cash flow from operations hit $15.3 billion[3], while dividends paid so far in 2026 totaled $2.6 billion. That is roughly 17% of operating cash flow. CVS ended the quarter with $6 billion[3] of cash at the parent and unrestricted subsidiaries, reached its leverage target ahead of schedule and plans to restart buybacks in the fourth quarter. The quarterly dividend has held at $0.665 for every payment from 2024-01-19 through 2026-10-22, with no cut, after increases from $0.50 in 2021.

Bull case: Aetna is recovering. The medical benefit ratio improved to 91.3% from 92.8%, and Health Care Benefits adjusted operating income rose to $912M from $314M. The company is now guiding to 2027 adjusted EPS of at least $8.65[3], which puts the stock at about 10 times that floor. CVS also plans to separate into two public companies, with completion expected in the first half of 2028[3]. CFO Brian Newman said on the Q3 call: "I can say with a high degree of confidence that both companies will be solid investment grade, with strong free cash flow generation."[3]

Risk: Management said medical cost trends remain elevated and expects that pressure to continue in 2027. The separation will also split one dividend stream into two, so income investors should keep an eye on how each board sets its payout. The stock has slipped 6.97% over the past month.

Cardinal Health: Thin Payout and Heavy Cash Flow

Current yield: Cardinal Health (NYSE:CAH) has the lowest yield in this group at about 0.74%, based on a forward dividend of $2.0632 and a price of $277.75. It earns its place on safety and growth. Shares have risen 36.42% year to date, and that rally has compressed the yield.

Dividend safety: The dividend uses only about 16% of the midpoint of raised FY27 non-GAAP EPS guidance of $12.80 to $13.00. FY26 free cash flow reached $4.525B[4], up 144.59%, and FY27 adjusted free cash flow guidance stands at $3.5B to $4.0B. The quarterly dividend rose from $0.175 in 2009 to 2010 to $0.5158, with the latest raise from $0.5107 coming in 2026. The board declared the next dividend on 2026-11-11. It goes ex-dividend 2027-01-04 and pays 2027-01-15.

Bull case: Q1 FY27 adjusted EPS of $3.26 beat the $2.94 estimate. Cardinal also signed a binding letter of intent to renew its pharmaceutical distribution agreements with CVS, which protects a key account in its largest segment. With a total buyback authorization of $6.4B[4], Cardinal has the means to keep reducing its share count while it raises the dividend. The stock trades at about 22 times the FY27 guidance midpoint.

Risk: Aggressive buybacks have pushed shareholders’ equity to -$2.866B. Cash flow covers obligations comfortably, but the company has less buffer than book value suggests. DOJ investigations and generic drug deflation are also worth tracking.

Omega Healthcare Investors: Nearly 6% Yield With Record-Low Leverage

Current yield: Omega Healthcare Investors (NYSE:OHI) pays an annualized $2.72 per share. At $47.18, it yields about 5.77%, the highest income in this group.

Dividend safety: For a REIT, adjusted funds from operations (AFFO) is the coverage metric that matters. Omega raised 2026 AFFO guidance to $3.28 to $3.30[5] per share, and the dividend uses about 83% of the $3.29[6] midpoint. In Q3, AFFO of $0.82[6] and FAD of $0.78 both covered the $0.68 quarterly payout. Leverage is 3.1x[6], the lowest in company history, and fixed charge coverage is 6.9x. Omega ended the quarter with no borrowings on its $2 billion[6] revolver. The dividend held at $0.67 from 2020 through 2026-05-04 before rising to $0.68.

Bull case: Operator EBITDAR coverage improved to 1.67x, and Omega has deployed about $1.5 billion[6] in new investments year to date. That includes an $845.7M[5] U.K. mortgage loan at 8.72%[5]. CEO Matthew Gourmand pointed on the Q3 call to "our lowest leverage in the company’s history, EBITDA coverage at the highest level in over a decade, robust secular tailwinds, and a portfolio of strong operators looking to grow."[6] An aging population supports long-term demand for skilled nursing beds.

Risk: Operator credit is the main exposure. Guidance assumes NewGen, which took over the Genesis lease after bankruptcy, pays full rent of $13.3 million per quarter and that no additional operators move to a cash basis. Medicaid reimbursement changes and pound sterling exposure from the U.K. book add further variables.

Four Ways to Collect Healthcare Income in December

Medtronic brings the longest raise streak, CVS offers a low payout ratio at a turnaround valuation, Cardinal Health brings the strongest coverage with a January check already declared, and Omega delivers the yield. All four cover their dividends with room to spare and have raised guidance this fall. Together, they draw healthcare income from four different parts of the system, the kind of staggered payout calendar we built an entire free guide around here.

Contact [email protected] for any questions or corrections.

Lee Jackson

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad, diverse career, including a stint as creative services director at an NBC affiliate in Austin, Texas, gives him unique insight into the financial industry.

Lee Jackson's journey in the financial industry spans more than 30 years, including nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career spanned pivotal sell-side Wall Street events, from the dot-com rise and bubble to the Long-Term Capital Management debacle, 9/11, and the Great Recession of 2008. This reflects his resilience and adaptability amid market volatility.

Lee Jackson’s practical financial industry experience, gained through a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing across various platforms. This unique combination allows him to shed light on the intricacies of Wall Street in a way only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

All articles →

Sources

  1. Medtronic plc. Form 8-K (Q4 FY2026)U.S. Securities and Exchange Commission
  2. Medtronic plc. Form 8-K (Q1 FY2027)U.S. Securities and Exchange Commission
  3. CVS Health Corporation Q3 2026 earnings callCVS Health Corporation
  4. Cardinal Health Form 8-K (Q4 FY2026)U.S. Securities and Exchange Commission
  5. Omega Healthcare Investors Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  6. Omega Healthcare Investors, Inc. Q3 2026 earnings callOmega Healthcare Investors, Inc.